申请人:Li Yun-Long
公开号:US20110224189A1
公开(公告)日:2011-09-15
The present invention provides compounds of the formula:
its enantiomers, diastereomers, racemic mixtures thereof, prodrugs, crystalline forms, non-crystalline forms, amorphous forms thereof, solvates thereof, metabolites thereof, and pharmaceutically acceptable salts, wherein the ring A substituent groups are fully defined in the following disclosure. The compounds of formula are inhibitors of metalloproteases such as matrix metalloproteases and sheddases, and are useful in treating diseases such as rheumatoid arthritis, psoriasis, neoplastic diseases, allergies and all those diseases wherein inhibition of MMPs is desirable.
本发明提供了化合物的公式:其对映异构体,对映体混合物,前药,晶体形式,非晶体形式,无定形形式,其溶剂化物,代谢产物以及药学上可接受的盐,其中环A的取代基在以下披露中完全定义。公式化合物是金属蛋白酶抑制剂,例如基质金属蛋白酶和剪切酶,并且在治疗风湿性关节炎,牛皮癣,肿瘤性疾病,过敏和所有需要抑制MMP的疾病中有用。